Keros Therapeutics Stock (NASDAQ: KROS) stock price, news, charts, stock research, profile.
You can purchase shares of Keros Therapeutics (NASDAQ:KROS) through any online brokerage.
Other companies in Keros Therapeutics’s space includes: KalVista Pharma (NASDAQ:KALV), Celcuity (NASDAQ:CELC), Upstream Bio (NASDAQ:UPB), Altimmune (NASDAQ:ALT) and Sage Therapeutics (NASDAQ:SAGE).
Keros Therapeutics has a consensus price target of $46.38.
The stock price for Keros Therapeutics (NASDAQ: KROS) is $10.32 last updated February 14, 2025 at 4:52 PM EST.
There are no upcoming dividends for Keros Therapeutics.
Keros Therapeutics’s Q1 earnings are confirmed for Wednesday, May 7, 2025.
There is no upcoming split for Keros Therapeutics.
Keros Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.